Merck nears $6bn biotech deal to boost cancer drug pipeline Sources: 2 articlesMerck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports (Reuters)Merck nears $6bn biotech deal to boost cancer drug pipeline (Financial Times News)